Track Celgene's total current liabilities ($19B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total current liabilities for CELG is $19B as of September 2026. That compares with $28B in the prior-year period — down 33.3% year over year. Investors often review this figure alongside Celgene's historical trend and sector peers before judging valuation or financial health.
Over the past year, CELG's total current liabilities moved from $28B to $19B — a 33.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Celgene's operating scale or balance-sheet position.
A total current liabilities figure of $19B for CELG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting CELG's total current liabilities ($19B), review year-over-year change from $28B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.